Smith Moore & CO. Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Smith Moore & CO. lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,136 shares of the biopharmaceutical company’s stock after acquiring an additional 432 shares […]